1. Home
  2. OCUP
  3. OCUP News

Latest Ocuphire Pharma Inc. (OCUP) News on July 27, 2024

Ocuphire Pharma to Highlight APX3330 for Diabetic Retinopathy at Two Scientific Meetings in July
OCUP

GlobeNewswire

17 days ago

Ocuphire Pharma to Highlight APX3330 for Diabetic Retinopathy at Two Scientific Meetings in July

Ocuphire Pharma Announces Presentations on the Development of APX3330 for Diabetic Retinopathy at Retina Meetings in June
OCUP

GlobeNewswire

2 months ago

Ocuphire Pharma Announces Presentations on the Development of APX3330 for Diabetic Retinopathy at Retina Meetings in June

Ocuphire Pharma First Quarter 2024 Earnings: Misses Expectations
OCUP

Simply Wall St.

2 months ago

Ocuphire Pharma First Quarter 2024 Earnings: Misses Expectations

Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update
OCUP

GlobeNewswire

3 months ago

Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update

Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting
OCUP

GlobeNewswire

3 months ago

Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting

Ocuphire Pharma to Present at the Aegis Virtual Conference
OCUP

GlobeNewswire

3 months ago

Ocuphire Pharma to Present at the Aegis Virtual Conference

Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting
OCUP

GlobeNewswire

3 months ago

Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting

First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine Ophthalmic Solution 0.75% (PS) for the Treatment of Decreased Visual Acuity Under Low Light Conditions Following Keratorefractive Surgery
OCUP

GlobeNewswire

3 months ago

First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine Ophthalmic Solution 0.75% (PS) for the Treatment of Decreased Visual Acuity Under Low Light Conditions Following Keratorefractive Surgery

Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris
OCUP

GlobeNewswire

4 months ago

Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris

Earnings Update: Ocuphire Pharma, Inc. (NASDAQ:OCUP) Just Reported And Analysts Are Trimming Their Forecasts
OCUP

Simply Wall St.

4 months ago

Earnings Update: Ocuphire Pharma, Inc. (NASDAQ:OCUP) Just Reported And Analysts Are Trimming Their Forecasts

Ocuphire Pharma Full Year 2023 Earnings: Misses Expectations
OCUP

Simply Wall St.

5 months ago

Ocuphire Pharma Full Year 2023 Earnings: Misses Expectations

Ocuphire Pharma Announces Financial Results for Fourth Quarter and Full Year 2023 and Provides Corporate Update
OCUP

GlobeNewswire

5 months ago

Ocuphire Pharma Announces Financial Results for Fourth Quarter and Full Year 2023 and Provides Corporate Update

Ocuphire Pharma to Present in the BIO CEO & Investor Conference
OCUP

GlobeNewswire

5 months ago

Ocuphire Pharma to Present in the BIO CEO & Investor Conference

Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
OCUP

GlobeNewswire

5 months ago

Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Ocuphire Pharma Strengthens Leadership Team with Key Appointments
OCUP

GlobeNewswire

5 months ago

Ocuphire Pharma Strengthens Leadership Team with Key Appointments

Ocuphire Pharma Announces Presentation on APX3330 at the Annual Angiogenesis, Exudation, and Degeneration 2024 Conference
OCUP

GlobeNewswire

6 months ago

Ocuphire Pharma Announces Presentation on APX3330 at the Annual Angiogenesis, Exudation, and Degeneration 2024 Conference

Why Fisker Stock Shot Higher Today
OCUP

Motley Fool

6 months ago

Why Fisker Stock Shot Higher Today

With the S&P 500 at a record high, strategists warn against a valuation 'trap'
OCUP

Yahoo Finance

6 months ago

With the S&P 500 at a record high, strategists warn against a valuation 'trap'

Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
OCUP

GlobeNewswire

6 months ago

Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Merck-Harpoon deal, Twilio, Crocs: Trending Tickers
OCUP

Yahoo Finance Video

7 months ago

Merck-Harpoon deal, Twilio, Crocs: Trending Tickers

New research highlights the positive impact of GLP-1s and other anti-obesity medications on the Allurion Program
OCUP

Business Wire

7 months ago

New research highlights the positive impact of GLP-1s and other anti-obesity medications on the Allurion Program

Novo Nordisk, The Weight-Loss Kingpin, Breaks Out After Inking Two New Deals In Obesity
OCUP

Investor's Business Daily

7 months ago

Novo Nordisk, The Weight-Loss Kingpin, Breaks Out After Inking Two New Deals In Obesity

Ocuphire Pharma Receives FDA Agreement Under Special Protocol Assessment for LYNX-2 Phase 3 Trial of Phentolamine Ophthalmic Solution for the Treatment of Decreased Visual Acuity under Dim (mesopic) Light Conditions
OCUP

GlobeNewswire

7 months ago

Ocuphire Pharma Receives FDA Agreement Under Special Protocol Assessment for LYNX-2 Phase 3 Trial of Phentolamine Ophthalmic Solution for the Treatment of Decreased Visual Acuity under Dim (mesopic) Light Conditions

AlphaTime Acquisition Corp Announces Adjournment of Extraordinary General Meeting of Shareholders
OCUP

GlobeNewswire

7 months ago

AlphaTime Acquisition Corp Announces Adjournment of Extraordinary General Meeting of Shareholders

Can Mixed Fundamentals Have A Negative Impact on AstroNova, Inc. (NASDAQ:ALOT) Current Share Price Momentum?
OCUP

Simply Wall St.

7 months ago

Can Mixed Fundamentals Have A Negative Impact on AstroNova, Inc. (NASDAQ:ALOT) Current Share Price Momentum?

Compugen will be Eligible to Receive $10 Million Milestone Payment upon Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer
OCUP

PR Newswire

7 months ago

Compugen will be Eligible to Receive $10 Million Milestone Payment upon Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer

inTEST Corporation Launches Next Generation of Induction Heating Systems
OCUP

Business Wire

7 months ago

inTEST Corporation Launches Next Generation of Induction Heating Systems

Adaptimmune Completes Submission of Rolling Biologics License Application (BLA) to U.S. FDA for Afami-cel for the Treatment of Advanced Synovial Sarcoma
OCUP

Newsfile

8 months ago

Adaptimmune Completes Submission of Rolling Biologics License Application (BLA) to U.S. FDA for Afami-cel for the Treatment of Advanced Synovial Sarcoma

OCUP

Business Wire

8 months ago

Certain Morgan Stanley Closed-End Funds Declare Year-End Dividends

Hedge funds investors have a lot riding on International Tower Hill Mines Ltd. (TSE:ITH) with 32% ownership
OCUP

Simply Wall St.

8 months ago

Hedge funds investors have a lot riding on International Tower Hill Mines Ltd. (TSE:ITH) with 32% ownership

Ocuphire Pharma Announces Presentation at Ophthalmology Innovation Summit (OIS) XIII
OCUP

GlobeNewswire

8 months ago

Ocuphire Pharma Announces Presentation at Ophthalmology Innovation Summit (OIS) XIII

inTEST Corporation to Participate in the 12th Annual NYC Summit
OCUP

Business Wire

8 months ago

inTEST Corporation to Participate in the 12th Annual NYC Summit

Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
OCUP

GlobeNewswire

8 months ago

Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Ocuphire Pharma Announces Appointment of Joseph Schachle, M.B.A., as Chief Operating Officer
OCUP

GlobeNewswire

8 months ago

Ocuphire Pharma Announces Appointment of Joseph Schachle, M.B.A., as Chief Operating Officer

Several Insiders Invested In California BanCorp Flagging Positive News
OCUP

Simply Wall St.

8 months ago

Several Insiders Invested In California BanCorp Flagging Positive News

EDAP to Present at Piper Sandler’s 35th Annual Healthcare Conference
OCUP

GlobeNewswire

8 months ago

EDAP to Present at Piper Sandler’s 35th Annual Healthcare Conference

Investing in Byrna Technologies (NASDAQ:BYRN) five years ago would have delivered you a 225% gain
OCUP

Simply Wall St.

8 months ago

Investing in Byrna Technologies (NASDAQ:BYRN) five years ago would have delivered you a 225% gain

Ocuphire Pharma Announces Financial Results for Third Quarter 2023 and Provides Corporate Update
OCUP

GlobeNewswire

8 months ago

Ocuphire Pharma Announces Financial Results for Third Quarter 2023 and Provides Corporate Update

Declining Stock and Solid Fundamentals: Is The Market Wrong About Ocuphire Pharma, Inc. (NASDAQ:OCUP)?
OCUP

Simply Wall St.

9 months ago

Declining Stock and Solid Fundamentals: Is The Market Wrong About Ocuphire Pharma, Inc. (NASDAQ:OCUP)?

SWK Holdings Corporation to Report Third Quarter 2023 Financial Results
OCUP

PR Newswire

9 months ago

SWK Holdings Corporation to Report Third Quarter 2023 Financial Results

OCUP

Thomson Reuters StreetEvents

9 months ago

Q3 2023 DHI Group Inc Earnings Call

Share on Social Networks: